Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Post by SamV21on Dec 31, 2022 12:36pm
251 Views
Post# 35198450

Akanda , Cap. 5 Mil. ,lost 8 Million last year, .15 cents

Akanda , Cap. 5 Mil. ,lost 8 Million last year, .15 cents Would seem right in line with Tetra , their stock price was over 11.00 this year now trading at .15 cents , seems like a company that would hook up with Guy . Reduvo not till March or April if at all Guy doesn't have the money to do anything with his Qixleef dream and add another 4 or 5 years to any dates he gives out as if you read the statements on the Tetra web site he stated he would be selling Reduvo by the end of 2018 . Dreams , all dreams and NO MONEY to complete them. Any update on the label from health Canada , we shareholders will be the last to know how close they are to halting the stock , thats how Guy operates , no communication and minimal updates to shareholders. 
<< Previous
Bullboard Posts
Next >>